phosphatidylcholines has been researched along with 5,8,11,14-eicosatetraynoic acid in 3 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (5,8,11,14-eicosatetraynoic acid) | Trials (5,8,11,14-eicosatetraynoic acid) | Recent Studies (post-2010) (5,8,11,14-eicosatetraynoic acid) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 573 | 1 | 16 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | 5,8,11,14-eicosatetraynoic acid (IC50) |
|---|---|---|---|
| Mcl-1 | Homo sapiens (human) | 1.78 | |
| Myeloid cell leukemia sequence 1 (BCL2-related) | Homo sapiens (human) | 0.4415 | |
| envelope glycoprotein | Human immunodeficiency virus 1 | 11.9 | |
| Vif | Human immunodeficiency virus 1 | 0.86 | |
| Tat | Human immunodeficiency virus 1 | 2.379 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 0.86 | |
| dual specificity protein phosphatase 6 | Rattus norvegicus (Norway rat) | 21.683 | |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | Homo sapiens (human) | 17.7 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 1.78 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 1.78 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 1.78 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 1.78 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 1.78 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Page Thomas, DP; Phillips, NC | 1 |
| Breitbart, H; Grossman, S; Lax, Y; Magid, N; Rubinstein, S | 1 |
| Mueller, GC; Wertz, PW | 1 |
3 other study(ies) available for phosphatidylcholines and 5,8,11,14-eicosatetraynoic acid
| Article | Year |
|---|---|
Intra-articular liposomal therapy.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Chronic Disease; Daunorubicin; Forecasting; Humans; Hydrocortisone; Ions; Liposomes; Methods; Pharmaceutical Vehicles; Phosphatidylcholines; Solubility; Structure-Activity Relationship; Temperature | 1979 |
Role of lipoxygenase in the mechanism of acrosome reaction in mammalian spermatozoa.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Acrosome; Animals; Arachidonate 15-Lipoxygenase; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Calcimycin; Calcium; Cattle; Cyclooxygenase Inhibitors; Hydroxyeicosatetraenoic Acids; Indomethacin; Lipoxygenase Inhibitors; Male; Masoprocol; Phosphatidylcholines; Spermatozoa | 1990 |
A possible role of protein alkylation in phorbol ester action.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Alkylation; Animals; Arachidonic Acid; Arachidonic Acids; Cattle; Choline-Phosphate Cytidylyltransferase; Enzyme Activation; Lymphocyte Activation; Lymphocytes; Nucleotidyltransferases; Oxygen; Phorbols; Phosphatidylcholines; Phytohemagglutinins; Proteins; Tetradecanoylphorbol Acetate; Tretinoin | 1982 |